<DOC>
	<DOCNO>NCT00425451</DOCNO>
	<brief_summary>The purpose study determine effect placement PerioChip Plus ( flurbiprofen/chlorhexidine - FBP/CHX ) formulation versus PerioChip ( chlorhexidine ) formulation versus Flurbiprofen Chip formulation versus Placebo Chip formulation probe pocket depth ( PPD )</brief_summary>
	<brief_title>The Efficacy Safety PerioChip Plus ( Flurbiprofen/Chlorhexidine ) Formulation Therapy Adult Periodontitis</brief_title>
	<detailed_description>This 80 subject , single-center , randomize , double-blinded , parallel , 4-arm clinical study ( 25 subject PerioChip Plus PerioChip arm 15 subject Flurbiprofen Chip Placebo Chip arm ) . At 24 week , relative baseline , mean reduction probe pocket depth ( PPD ) use primary efficacy endpoint . Additional primary endpoint clinical attachment level ( CAL ) bleed probe ( BOP ) target pocket select screening , measure week 24 . PPD measurement 6 , 12 18 week use secondary endpoint . Additional secondary endpoint clinical attachment level ( CAL ) bleed probe ( BOP ) target pocket select screening , measure week 6 , 12 18 .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>Signed informed consent form Good general health Male female subject age &gt; 25 year old Minimum 8 natural teeth Availability 25 week duration study Periodontal disease natural teeth characterize presence least 2 teeth periodontal pocket 69 mm depth ( target teeth ) order reach baseline ( day 1 ) periodontal pocket 58 mm depth , without involve apex tooth . Females childbearing potential must non pregnant entry agree use adequate method birth control study . Demonstrate bleed probe base pocket pocket ( site ) select time screen . Presence oral local mechanical factor could ( opinion investigator ) influence outcome study . Presence orthodontic appliance removable appliance impinges tissue assess . Soft hard tissue tumours oral cavity . Presence dental implant adjacent target tooth . Periodontal pocket 9 mm depth . General systemic antibiotic therapy periodontal/mechanical/local delivery therapy within 6 week prior study entry study duration . History allergy chlorhexidine , flurbiprofen nonsteroidal antiinflammatory drug ( NSAIDs ) . Subjects take diphenylhydantoin , nifedepine and/or cyclosporine , might influence pattern tissue response . Subject treat nonsteroidal antiinflammatory drug ( NSAIDs ) within 14 day prior entry study study duration . Pregnant woman plan become pregnant lactating woman . Presence follow condition : Type 1 diabetes , major recurrent aphtae , stomatitis related oral pathology . The presence medical psychiatric condition condition opinion investigator could affect successful participation subject study . Subject participate clinical study 30 day prior start study study duration . Subject use chlorhexidine oral rinses/ mouthwash regular basis .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Periodontitis</keyword>
	<keyword>Dental Care</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>